IBDEI06V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2696,2)
 ;;=^5000670
 ;;^UTILITY(U,$J,358.3,2697,0)
 ;;=B45.8^^7^83^45
 ;;^UTILITY(U,$J,358.3,2697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2697,1,3,0)
 ;;=3^Cryptococcosis NEC
 ;;^UTILITY(U,$J,358.3,2697,1,4,0)
 ;;=4^B45.8
 ;;^UTILITY(U,$J,358.3,2697,2)
 ;;=^5000674
 ;;^UTILITY(U,$J,358.3,2698,0)
 ;;=A07.2^^7^83^49
 ;;^UTILITY(U,$J,358.3,2698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2698,1,3,0)
 ;;=3^Cryptosporidium infection
 ;;^UTILITY(U,$J,358.3,2698,1,4,0)
 ;;=4^A07.2
 ;;^UTILITY(U,$J,358.3,2698,2)
 ;;=^29629
 ;;^UTILITY(U,$J,358.3,2699,0)
 ;;=B25.9^^7^83^52
 ;;^UTILITY(U,$J,358.3,2699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2699,1,3,0)
 ;;=3^Cytomegaloviral disease, unspecified
 ;;^UTILITY(U,$J,358.3,2699,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,2699,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,2700,0)
 ;;=A90.^^7^83^53
 ;;^UTILITY(U,$J,358.3,2700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2700,1,3,0)
 ;;=3^Dengue Fever
 ;;^UTILITY(U,$J,358.3,2700,1,4,0)
 ;;=4^A90.
 ;;^UTILITY(U,$J,358.3,2700,2)
 ;;=^5000439
 ;;^UTILITY(U,$J,358.3,2701,0)
 ;;=B35.4^^7^83^55
 ;;^UTILITY(U,$J,358.3,2701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2701,1,3,0)
 ;;=3^Dermatophytosis,Body
 ;;^UTILITY(U,$J,358.3,2701,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,2701,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,2702,0)
 ;;=B35.3^^7^83^56
 ;;^UTILITY(U,$J,358.3,2702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2702,1,3,0)
 ;;=3^Dermatophytosis,Foot
 ;;^UTILITY(U,$J,358.3,2702,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,2702,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,2703,0)
 ;;=B35.1^^7^83^54
 ;;^UTILITY(U,$J,358.3,2703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2703,1,3,0)
 ;;=3^Dermathphytosis,Nail
 ;;^UTILITY(U,$J,358.3,2703,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,2703,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,2704,0)
 ;;=E11.9^^7^83^59
 ;;^UTILITY(U,$J,358.3,2704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2704,1,3,0)
 ;;=3^Diabetes, type II controlled
 ;;^UTILITY(U,$J,358.3,2704,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,2704,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,2705,0)
 ;;=E11.65^^7^83^60
 ;;^UTILITY(U,$J,358.3,2705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2705,1,3,0)
 ;;=3^Diabetes, type II uncontrolled
 ;;^UTILITY(U,$J,358.3,2705,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,2705,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,2706,0)
 ;;=E10.9^^7^83^58
 ;;^UTILITY(U,$J,358.3,2706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2706,1,3,0)
 ;;=3^Diabetes, type I
 ;;^UTILITY(U,$J,358.3,2706,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,2706,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,2707,0)
 ;;=R19.7^^7^83^62
 ;;^UTILITY(U,$J,358.3,2707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2707,1,3,0)
 ;;=3^Diarrhea, unspecified
 ;;^UTILITY(U,$J,358.3,2707,1,4,0)
 ;;=4^R19.7
 ;;^UTILITY(U,$J,358.3,2707,2)
 ;;=^5019276
 ;;^UTILITY(U,$J,358.3,2708,0)
 ;;=A09.^^7^83^61
 ;;^UTILITY(U,$J,358.3,2708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2708,1,3,0)
 ;;=3^Diarrhea, infectious
 ;;^UTILITY(U,$J,358.3,2708,1,4,0)
 ;;=4^A09.
 ;;^UTILITY(U,$J,358.3,2708,2)
 ;;=^5000061
 ;;^UTILITY(U,$J,358.3,2709,0)
 ;;=K57.92^^7^83^64
 ;;^UTILITY(U,$J,358.3,2709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2709,1,3,0)
 ;;=3^Diverticulitis
 ;;^UTILITY(U,$J,358.3,2709,1,4,0)
 ;;=4^K57.92
 ;;^UTILITY(U,$J,358.3,2709,2)
 ;;=^5008737
 ;;^UTILITY(U,$J,358.3,2710,0)
 ;;=R42.^^7^83^65
 ;;^UTILITY(U,$J,358.3,2710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2710,1,3,0)
 ;;=3^Dizziness/light-headedness
 ;;^UTILITY(U,$J,358.3,2710,1,4,0)
 ;;=4^R42.
 ;;^UTILITY(U,$J,358.3,2710,2)
 ;;=^5019450
 ;;
 ;;$END ROU IBDEI06V
